Mark Drugs Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 26-12-2024
- Paid Up Capital ₹ 4.21 M
as on 26-12-2024
- Company Age 29 Year, 11 Months
- Open Charges ₹ 3.60 M
as on 26-12-2024
About Mark Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.21 M.
The company currently has active open charges totaling ₹3.60 M.
Anandam Dyavanapally and Rajalingam Dyavanapalli serve as directors at the Company.
- CIN/LLPIN
U24239TG1995PLC019228
- Company No.
019228
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1995
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationNa, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mark Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anandam Dyavanapally  | Director | 18-Jan-1995 | Current |
| Rajalingam Dyavanapalli | Director | 18-Jan-1995 | Current |
Financial Performance of Mark Drugs.
Enhance accessibility to Mark Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mark Drugs?
Unlock access to Mark Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 11 Feb 1999 | ₹1.80 M | Open |
Canara Bank Creation Date: 22 Feb 1997 | ₹1.80 M | Open |
How Many Employees Work at Mark Drugs?
Unlock and access historical data on people associated with Mark Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mark Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
